Trial of CUDC-907 in Children and Young Adults With Relapsed or Refractory Solid Tumors, CNS Tumors, or Lymphoma
Dana-Farber Cancer Institute
Dana-Farber Cancer Institute
UNC Lineberger Comprehensive Cancer Center
Virginia Commonwealth University
Washington University School of Medicine
Cedars-Sinai Medical Center
BPGbio
Dana-Farber Cancer Institute
Children's Oncology Group
Dana-Farber Cancer Institute
St. Jude Children's Research Hospital
Seattle Children's Hospital
M.D. Anderson Cancer Center
Children's Hospital Medical Center, Cincinnati
Northwestern University
Virginia Commonwealth University
National Institutes of Health Clinical Center (CC)
Celgene
National Institutes of Health Clinical Center (CC)
Acrotech Biopharma Inc.
University of Michigan Rogel Cancer Center
British Columbia Cancer Agency
Albert Einstein College of Medicine
St. Jude Children's Research Hospital
AHS Cancer Control Alberta
Memorial Sloan Kettering Cancer Center
Stanford University
St. Jude Children's Research Hospital
St. Jude Children's Research Hospital
INSYS Therapeutics Inc
University of South Florida
Children's Oncology Group
National Cancer Institute (NCI)
Novartis
Duke University
City of Hope Medical Center
National Cancer Institute (NCI)
National Institute of Allergy and Infectious Diseases (NIAID)
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
Case Comprehensive Cancer Center
Georgetown University